المؤلفون: Vincenzi B., Nannini M., Badalamenti G., Grignani G., Fumagalli E., Gasperoni S., D'Ambrosio L., Incorvaia L., Stellato M., Spalato Ceruso M., Napolitano A., Valeri S., Santini D., Tonini G., Casali P. G., Dei Tos A. P., Pantaleo M. A.

المساهمون: Vincenzi B., Nannini M., Badalamenti G., Grignani G., Fumagalli E., Gasperoni S., D'Ambrosio L., Incorvaia L., Stellato M., Spalato Ceruso M., Napolitano A., Valeri S., Santini D., Tonini G., Casali P.G., Dei Tos A.P., Pantaleo M.A.

مصطلحات موضوعية: exon 11 KIT mutation, GIST, imatinib, rechallenge, TKI

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30181783; info:eu-repo/semantics/altIdentifier/wos/WOS:000444991000001; volume:10; numberofpages:8; journal:THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY; http://hdl.handle.net/10447/437167Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054631441

الإتاحة: https://doi.org/10.1177/1758835918794623Test
http://hdl.handle.net/10447/437167Test

المؤلفون: Paige S, Jones M, D'Ambrosio L, Taylor W, Bonne D, Loehr M, Stergachis A

المصدر: Public Health Reports; May/Jun2010, Vol. 125 Issue 3, p488-493, 6p